# Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)

> **NCT00918489** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 40 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT00918489
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00918489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00918489, "Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00918489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*